Treatment and pain management
Many different therapies have been employed to alleviate the pain of peripheral neuropathy and reverse some of the nerve damage. While some of these have been shown to be effective in HIV-related neuropathy, many studies have failed to distinguish between neuropathy caused by HIV itself and neuropathy as a side-effect of anti-HIV drugs. In addition, many treatments have been tested in the similar condition seen in diabetics. Whether these results can be applied to HIV-positive patients is uncertain.
latest aidsmap news
- High rate of death amongst patients with HIV diagnosed late
- CD4 cell count increases sustained up to five years in developing-world treatment programmes
- Raltegravir may have role in PEP if exposure involves drug-resistant HIV
- Excellent outcomes from five years of antiretroviral use in Botswana
- Study explores verbal and non-verbal communication in unprotected sex between men
- IL-2 provides quick ‘AIDS rescue’, but effect does not always last
- Once-a-day etravirine should work as first-line treatment
- Second-line combinations fail twice as often as first-line ones in the first year
- If you can't switch, better to stay on failing treatment than stop it, studies show
- Non-nucleoside resistance is efficiently transmitted within infection ‘clusters’